Michael Mullen, MD
Otolaryngology · Mount Vernon, WANPI 1174029078
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,580 of the $2,129 with a category attached, or 74.2%. Smith+Nephew accounts for 86.3% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $1,868 and has fallen 89.4% since, to $199 in 2025.
Across 15 payments — averaging $141.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$2K
- Inspire Medical Systems, Inc.$144
- Medtronic$34
- Aerin Medical Inc.$33
- Cochlear Americas$31
- Johnson & Johnson$29
- plus $22 from 1 others
What the payments were for
- Travel & lodging$1,58074%
- Food & beverage$54926%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 7 | $1,837 |
| Inspire Medical Systems, Inc. | 2 | $144 |
| Medtronic | 2 | $34 |
| Aerin Medical Inc. | 1 | $33 |
| Cochlear Americas | 1 | $31 |
| Johnson & Johnson | 1 | $29 |
| GSK | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,129 in reported general payments places this provider in the 80th percentile of 254 otolaryngology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 100 | $2,656 |
| Fluticasone Propionate | 66 | $856 |
| Ofloxacin | 16 | $652 |
| Omeprazole | 14 | $385 |
| Azelastine Hcl | 11 | $248 |
| Mometasone Furoate | 25 | $185 |
| Cephalexin | 14 | $122 |
| Methylprednisolone | 12 | $86 |
| Oxycodone Hcl | 25 | $81 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Mount Vernon
- Greg DavisPuyallup$531K
- Ian HumphreysSeattle$43K
- Douglas BackousPuyallup$36K
- Craig MillerSeattle$24K
- Sachin GuptaSeattle$23K
- Sharon CushingSeattle$19K
- Ronald KruegerMukilteo$19K
- Eric WatermanBellevue$15K
- Ryan SternFederal Way$15K
- Todd BerinsteinVancouver$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.